Original ResearchPublished 10 June 2026Methodological comparisons for benefit-risk assessment in complex decision-making: applications and insights from a case studyJian-Yu E · Kexin Zhu · Stéphanie Tcherny-Lessenot · Juhaeri JuhaeriFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2026.1792441
Original ResearchPublished 7 May 2026Global pharmacovigilance reporting: comparative analysis of adverse event obligations across five major regulatory authoritiesCarlos G. Bernaus · Maria Lilia BournissenFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2026.1821686
